U.S. Healthcare: A Two-Decade Review of Health Spans and Spending

A new national study published in Value in Health examined changes in health-adjusted life expectancy (HALE) and lifetime healthcare spending in the U.S. between 1996 and 2016. Researchers evaluated 132 causes of disease across all ages.

The study found that improvements in medical care over two decades increased health spans in the U.S. by 1.3 years and medical spending by an average of $234,000 per person over their lifetime when measured from birth. This translates to approximately $182,000 per additional healthy year of life gained.

Diverse Outcomes Across Conditions

Key findings indicate that bolstering healthcare resources for about 60% of conditions, including ischemic heart disease, stroke, and HIV/AIDS, resulted in substantial health gains at relatively modest costs.

"For instance, better treatments for HIV/AIDS led to significant increases in survival and quality of life at a cost of $9,300 per healthy year gained."

Nineteen causes (14%), such as breast cancer, showed increased HALE and decreased lifetime spending due to cost-saving advances in screening and treatment. In contrast, HALE decreased while lifetime spending increased for 26 causes (20%), including chronic kidney disease and drug use disorders. Drug use disorders were noted to significantly worsen the overall value of U.S. healthcare during the study period.

The Value of Early Investment

When calculating the value of health care starting at age 65, the cost per healthy year gained dropped to about $92,000, roughly half the estimate from birth. This highlights how early investments can benefit long-term health, particularly for chronic diseases.

"When calculating the value of health care starting at age 65, the cost per healthy year gained dropped to about $92,000, roughly half the estimate from birth."

Recommendations for Future Healthcare

Researchers suggest that efforts to control healthcare costs should prioritize improving access to care for interventions that deliver meaningful health improvements, rather than implementing across-the-board spending cuts. Further research and innovation are identified as necessary for conditions that lead to high costs without corresponding health improvements.